Slick channel protein (KCNT2), also known as Slo2.1, is a sodium-activated potassium channel closely related to Slack (KCNT1). This page provides comprehensive information about its structure, function, and role in neuronal physiology and disease.
Slick Channel Protein is encoded by the KCNT2 gene, a member of the Slo2 family of sodium-activated potassium channels[1]. The human KCNT2 gene encodes a protein of approximately 1048 amino acids with a molecular weight of approximately 110 kDa[2]. The UniProt ID is Q6ZNC8.
Slick channels are highly expressed in the brain and retina, where they play crucial roles in regulating neuronal excitability and retinal function[3]. Together with Slack (KCNT1), Slick channels comprise the primary sodium-activated potassium channel family in mammals.
Slick channels share structural features with Slack channels:
The structural similarity between Slick and Slack underlies their overlapping functional properties, though they exhibit distinct pharmacological and biophysical characteristics[4].
Slick channels, like Slack channels, are activated by intracellular sodium ions:
Slick channels exhibit distinctive expression patterns:
Brain Regions:
Retina:
Other Tissues:
Neuronal Excitability: Slick channels contribute to membrane repolarization and regulation of firing patterns, particularly during periods of high neuronal activity[5].
Retinal Signaling: In the retina, Slick channels modulate photoreceptor responses and bipolar cell signaling, contributing to visual processing[6].
Metabolic Regulation: Similar to Slack, Slick channels function as metabolic sensors, activating during conditions of cellular energy stress.
Noise Filtering: Slick channels help maintain stable neuronal firing by reducing membrane potential fluctuations.
While less frequently mutated than KCNT1, KCNT2 variants have been associated with:
Slick channel dysfunction may contribute to retinal diseases:
Neuropathic Pain: Slick channels in sensory neurons may play roles in pain signaling[7].
Migraine: Some evidence suggests sodium-activated potassium channels in trigeminal neurons may be relevant to migraine pathophysiology.
Alzheimer's Disease: Altered Slick channel expression has been reported in AD models, potentially contributing to neuronal excitability changes.
Parkinson's Disease: Similar to Slack, Slick channels may be affected by metabolic dysfunction in dopaminergic neurons.
Slick channel pharmacology overlaps with but is distinct from Slack:
Activators:
Inhibitors:
KCNT2 is evolutionarily conserved across vertebrates, with orthologs in:
Common polymorphisms in KCNT2 have been studied for associations with:
Slick and Slack channels share many properties but have distinct features:
| Property | Slick (KCNT2) | Slack (KCNT1) |
|---|---|---|
| Gene | KCNT2 | KCNT1 |
| Size | ~110 kDa | ~95 kDa |
| Na+ sensitivity | Similar | Similar |
| Brain expression | High | High |
| Retina expression | High | Lower |
| Disease associations | Fewer known | Epilepsy, AD, PD |
Both channels can form heteromeric complexes, creating channels with intermediate properties[8].
Slick (KCNT2) channels are sodium-activated potassium channels critical for neuronal excitability, retinal function, and metabolic stress responses. While less studied than their Slack counterparts, Slick channels play essential roles in multiple physiological systems and represent potential therapeutic targets for neurological and retinal disorders. Further research is needed to fully elucidate Slick channel functions and their implications for disease.
Salkoff L, Butler A, Ferreira G, et al. High-conductance potassium channels of the SLO family. Nature Reviews Neuroscience. 2006. ↩︎
UniProt Consortium. KCNT2 - Slick channel protein. UniProtKB Q6ZNC8. UniProt. ↩︎
Bhattacharjee A, Gan L, Kaczmarek LK. Localization of the Slack potassium channel in the rat central nervous system. Journal of Comparative Neurology. 2002. ↩︎
Yuan A, Santi CM, Krishnan A, et al. The sodium-activated potassium channel is encoded by a Slo gene. Cell. 2003. ↩︎
Gu N, Vervaeke K, Storm JF. Slack and Slick potassium channels in pyramidal neurons. Neuropharmacology. 2007. ↩︎
Krizaj D, Liu XL, Cui K. Expression of Slack potassium channels in the mouse retina. Visual Neuroscience. 2014. ↩︎
Martinez-Espinosa PL, Yang C, Perez X, et al. Knockout of Slo2.2 enhances itch, alters dorsal horn neuronal excitability, and reduces analgesic efficacy of potassium channel openers. Journal of Neuroscience. 2022. ↩︎
Brown MR, Kronengold J, Gazula VR, et al. Amino-terminal mutations in the human Slack sodium-activated potassium channel improve splicing. Proceedings of the National Academy of Sciences. 2013. ↩︎